Cloned (Comment) | Organism |
---|---|
N-terminal hexa-His-NS5BD21 (Con1 strain, GT1b with the C-terminal 21-amino acid membrane anchor domain deleted), expression in Escherichia coli | Hepacivirus C |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
2'-fluoro-2'C-methylcytidine-5'-triphosphate | acts as a chain terminator after incorporated during RNA synthesis. It is readily incorporated into a growing primer by NS5B but is also efficiently excised | Hepacivirus C | |
2'-fluoro-2'C-methyluridine-5'-triphosphate | acts as a chain terminator after incorporated during RNA synthesis. It is readily incorporated into a growing primer by NS5B but is also efficiently excised. Although 2'C-modified CTP analogs are more efficiently incorporated compared with the UTP analog, the UTP analog is a better inhibitor because of its resistance to ATP-dependent excision | Hepacivirus C | |
2'C-methylcytidine triphosphate | acts as a chain terminator after incorporated during RNA synthesis. It is readily incorporated into a growing primer by NS5B but is also efficiently excised | Hepacivirus C | |
4'-azido-cytidine triphosphate | acts as a chain terminator after incorporated during RNA synthesis. It is readily incorporated into a growing primer by NS5B but is also efficiently excised | Hepacivirus C | |
sofosbuvir | the clinical effectiveness of sofosbuvir is largely a function of being intractable to nucleotide-mediated excision compared with similar nucleoside analogs | Hepacivirus C |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Hepacivirus C | - |
- |
- |
Purification (Comment) | Organism |
---|---|
- |
Hepacivirus C |
Synonyms | Comment | Organism |
---|---|---|
NS5B | - |
Hepacivirus C |
RNA-dependent RNA polymerase | - |
Hepacivirus C |
General Information | Comment | Organism |
---|---|---|
physiological function | the enzyme catalyzes the replication of the hepatitis C virus genome | Hepacivirus C |